ClinicalTrials.gg
CompletedNCT04270825Updated Feb 10, 2021

Group Treatment for Hoarding Disorder

An interventional study of Group CBT with IPT in Hoarding Disorder, sponsored by Florida State University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-10.

Sponsored by Florida State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study assesses the effectiveness of a novel group treatment for hoarding disorder.

Read the detailed description

The primary aim of this study is to investigate the effectiveness of a novel group treatment for hoarding disorder. Participants will be randomized to receive either treatment as usual (cognitive behavioral therapy: CBT) or treatment as usual augmented by interpersonal psychotherapy (IPT). It is hypothesized that group CBT with IPT will result in greater decreases in hoarding symptoms, as compared to standard group CBT. It is further hypothesized that CBT with IPT will result in greater reductions in object attachment and maladaptive beliefs about relationships with others, as well as greater increases in interpersonal attachment.

02

Conditions studied

  • Hoarding Disorder

Browse trials for

03

In context

Hoarding Disorder

32 studies on the registry are indexed under Hoarding Disorder; 5 are open to participants now.

This study's enrollment of 8 is below the median of 37 across 28 interventional studies indexed under Hoarding Disorder.

Browse Hoarding Disorder studies →

Lead sponsor

Florida State University is the lead sponsor of 249 studies on the registry; 47 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 9 (56%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-Clinical diagnosis of HD

Exclusion criteria

Exclusion Criteria:

  • Evidence of a severe mental illness or substance use disorder that would impede the completion of the treatment
  • Current receipt of CBT for HD
  • Initiation of new psychotropic medications for symptoms of HD
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    CBT with IPT

    Group CBT with IPT will consist of 20 weekly two-hour sessions and has been developed for the proposed study based on the protocols for group CBT for HD and group IPT. Treatment includes strategies from CBT, including cognitive restructuring, behavioral exposures, and organizational strategies, as well as strategies from IPT, including role-play, interpersonal skills building, communication analysis, and decision analysis.

    Behavioral: Group CBT with IPT

Interventions

  • BehavioralGroup CBT with IPT

    Group treatment designed to target relationships with both possessions and people.

06

What researchers measure

Primary outcomes

  1. Changes in Hoarding Rating Scale (HRS)

    The Hoarding Rating Scale is a commonly used measure of hoarding symptoms in which participants rate the severity of their symptoms. Minimum score is 0 and maximum score is 40. Higher scores indicate more severe/worse symptoms.

    Time frame: Baseline, 10 weeks, 20 weeks, 24 weeks

  2. Changes in Reciprocal Attachment Questionnaire Adapted (RAQ-A)

    The Reciprocal Attachment Questionnaire Adapted assesses attachment to one's belongings, with higher scores indicating greater attachment to possessions (i.e., worse outcome). Minimum score is 75 and maximum score is 375.

    Time frame: Baseline, 10 weeks, 20 weeks, 24 weeks

  3. Changes in Adult Attachment Scale (AAS)

    The AAS is a measure of two dimensions proposed to underlie interpersonal attachment security: anxiety and avoidance. Higher scores indicate worse outcomes. Minimum score is 0 and maximum score is 72.

    Time frame: Baseline, 10 weeks, 20 weeks, 24 weeks

  4. Changes in Interpersonal Needs Questionnaire (INQ)

    The INQ is a measure of two interpersonal risk factors, namely perceived burdensomeness and thwarted belongingness, with higher scores indicating higher levels of each construct (i.e., worse outcome). Minimum score is 15 and maximum score is 105.

    Time frame: Baseline, 10 weeks, 20 weeks, 24 weeks

07

Study locations

1 site
  • Florida State University
    Tallahassee, Florida 32304, United States
08

References and documents

Individual participant data

Plan to share: No — Data will not be shared.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2019 to primary completion in May 2020, 7 months.

Of 20 interventional studies with no phase under Hoarding Disorder, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 48. This study's 7 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2019
First posted
Feb 17, 2020
StartActual
Oct 1, 2019
Primary completionActual
May 31, 2020
CompletionActual
May 31, 2020
Last update
Feb 10, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04270825
Responsible party
Brittany Mathes (Graduate Student, Florida State University) — Principal investigator
First posted
Feb 17, 2020
Start date
Oct 1, 2019
Primary completion
May 31, 2020
Completion
May 31, 2020
Last update
Feb 10, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion